Why Is LUMEXA IMAGING HLDGS (LMRI) Stock Up Today?

Lumexa Imaging Holdings (LMRI) shares rose 12.64% to $15.68, driven by a strong third quarter earnings report that exceeded expectations. The company also raised its full-year adjusted earnings per share guidance, signaling confidence in its financial trajectory.

What Happened

Lumexa reported third quarter non-GAAP earnings per share of $0.26, beating the consensus estimate of $0.18 by $0.08. Revenue came in at $272 million, surpassing the $269.894 million estimate by $2.11 million and representing a 5.1% year-over-year increase. Management reaffirmed its fiscal 2026 revenue guidance of $1.045 billion to $1.097 billion. Additionally, the company raised its adjusted EPS guidance for the full year from a previous range of $0.71 to $0.77 to a new range of $0.86 to $0.90, well above the $0.77 estimate. Raymond James raised its price target on the stock from $17 to $19 following the results.

What The Data Shows

The stock opened at $14.10, a 1.3% gap up from the prior close of $13.92. It reached a session high of $16.08 at 9:30 AM ET and a low of $14.09 at 9:25 AM ET. Over the last eight sessions, the stock has climbed 22.0%, moving from $11.41 to $13.92 before today’s jump. The 52-week range is $6.45 to $19.45. The company remains unprofitable on a trailing twelve-month basis with an EPS of -0.33 and a net margin of -2.7%, though revenue has grown 7.8% over the same period. The market capitalization stands at $1.3 billion.

What To Watch

Investors will monitor how the stock performs against the new $19 price target set by Raymond James. The company’s ability to maintain its raised adjusted EPS guidance and expand its advanced imaging mix will be key factors in the coming quarters.